Ani Pharmaceuticals (ANIP) Tops Q1 EPS by 1c

Ani Pharmaceuticals (NASDAQ: ANIP) reported Q1 EPS of $0.33, $0.01 better than the analyst estimate of $0.32. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $11.4 million.

For earnings history and earnings-related data on Ani Pharmaceuticals (ANIP) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group